# RIFAMPIN
> **ANDA065421** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2008-05-22
## Drug
- **FDA Application Number:** ANDA065421
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAMPIN
- **Generic name:** RIFAMPIN
- **Active ingredients:** RIFAMPIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2008-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065421)
---
*AI Analytics · CC0 1.0*